Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T- lineage leukemic blasts: A Children's Cancer Group study

Journal of Clinical Oncology

Volumn 15, Issue 6, 1997, Pages 2214-2221

  Uckun, Fatih M ^a   Gaynon, Paul S ^a   Sensel, Martha G ^a   Nachman, James ^a   Trigg, Michael E ^a   Steinherz, Peter G ^a   Hutchinson, Raymond ^a   Bostrom, Bruce C ^a   Sather, Harland N ^a   Reaman, Gregory H ^a  

^a PARKER HUGHES INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; MEMBRANE ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONTOGENY; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

EID: 0030903602     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.6.2214     Document Type: Article

References (46)

1. Reinherz EL, Kung PC, Goldstein G, et al: Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci USA 77:1588-1592, 1980
2. Roper M, Crist WM, Metzgar R, et al: Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies. Blood 61:830-837, 1983
3. Haynes BF, Martin ME, Kay HH, et al: Early events in human T-cell ontogeny. Phenotypic characterization and immunohistologic localization of T-cell precursors in early human fetal tissues. J Exp Med 168:1061-1080, 1988 (published erratum appears in J Exp Med 169:603, 1989)
4. Haynes BF, Denning SM, Singer KH, et al: Ontogeny of T-cell precursors: A model for the initial stages of human T-cell development. Immunol Today 10:87-91, 1989
5. Campana D, Janossy G, Coustan-Smith E, et al: The expression of T-cell receptor-associated proteins during T-cell ontogeny in man. J Immunol 142:57-66, 1989
6. Barcena A, Muench MO, Galy AH, et al: Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus: CD7 expression in the early stages of T- and myeloid-cell development. Blood 82:3401-3414, 1993
7. Terstappen LW, Huang S, Picker LJ: Flow cytometric assessment of human T-cell differentiation in thymus and bone marrow. Blood 79:666-677, 1992
8. Pullen DJ, Falletta JM, Crist WM, et al: Southwest Oncology Group experience with immunological phenotyping in acute lymphoeytic leukemia of childhood. Cancer Res 41:4802-4809, 1981
9. Pullen DJ, Boyett JM, Crist WM, et al: Pediatric oncology group utilization of immunologic markers in the designation of acute lymphocytic leukemia subgroups: Influence on treatment response. Ann NY Acad Sci 428:26-48, 1984
10. Pui CH, Behm FG, Singh B, et al: Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood 75:174-179, 1990
11. Crist W, Boyett J, Pullen J, et al: Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: A Pediatric Oncology Group review. Med Pediatr Oncol 14:135-139, 1986
12. Crist WM, Shuster JJ, Falletta J, et al: Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: A Pediatric Oncology Group study. Blood 72:1891-1897, 1988
13. Ludwig WD, Teichmann JV, Sperling C, et al: Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: Experiences of the ALL-BFM 83 and 86 studies. Klin Padiatr 202:243-252, 1990
14. Garand R, Bene MC: Incidence, clinical and laboratory features, and prognostic significance of immunophenotypic subgroups in acute lymphoblastic leukemia: The GEIL experience. Recent Res Cancer Res 131:283-295, 1993
15. Greaves MF: Differentiation-linked leukemogenesis in lymphocytes. Science 234:697-704, 1986
16. Jacobs JC, Rearden A: CD7-positive acute leukemia lacking T-cell receptor gene rearrangements and terminal deoxynucleotidyl transferase expression suggesting pre-T-cell origin. Am J Hematol 32:212-216, 1989
17. Kurtzberg J, Waldmann TA, Davey MP, et al: CD7+, CD4-, CD8- acute leukemia: A syndrome of malignant pluripotent lymphohematopoietic cells. Blood 73:381-390, 1989
18. Champlin R, Gale RP: Acute lymphoblastic leukemia: Recent advances in biology and therapy [see comments]. Blood 73:2051-2066, 1989
19. Gaynon P, Steinherz P, Bleyer WA, et al: Intensive therapy for children with acute lymphoblastic leukemia and unfavorable presenting features. Lancet 2:921-924, 1988
20. Steinherz PG, Gaynon P, Miller DR, et al: Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen - A new intensive therapy protocol: A report from the Childrens Cancer Study Group. J Clin Oncol 4:744-752, 1986
21. Tubergen D, Gilchrist G, O'Brien A, et al: Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features. J Clin Oncol 11:527-537, 1993
22. Steinherz PG, Siegel SE, Bleyer WA, et al: Lymphomatous presentation of childhood acute lymphoblastic leukemia. Cancer 68:751-758, 1991
23. Smith M, Arthur D, Camitta B, et al: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia [see comments]. J Clin Oncol 14:18-24, 1996
24. Gaynon PS, Steinherz PG, Bleyer WA, et al: Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: A follow-up report of the Childrens Cancer Group study CCG-106. J Clin Oncol 11:2234-2242, 1993
25. Uckun FM, Ledbetter JA: Immunobiologic differences between normal and leukemic human B-cell precursors. Proc Natl Acad Sci USA 85:8603-8607, 1988
26. Uckun FM, Muraguchi A, Ledbetter JA, et al: Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 73:1000-1015, 1989
27. Uckun FM, Gajl-Peczalska KJ, Provisor AJ, et al: Immunophenotype-karyotype associations in human acute lymphoblastic leukemia. Blood 73:271-280, 1989
28. Hollander M, Wolfe D: Nonparametric Statistical Methods. New York, NY, Wiley, 1973
29. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
30. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
31. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-8, 1977
32. Thomas D, Breslow N, Gart J: Trend and homogeneity analyses of proportions and life table data. Comp Biomed Res 10:373-381, 1977
33. Breslow N: Comparison of survival curves, in Buyse M, Staquet M, Sylvester M (eds): Cancer Clinical Trials: Methods and Practice. Oxford, United Kingdom, Oxford University, 1988, pp 381-406
34. Cox DR: Regression models and life tables. Royal Stat Soc B 34:187-220, 1972
35. Breslow N: Analysis of survival data under the proportional hazards model. Int Stat Rev 43:45-58, 1975
36. Bleyer WA, Sather H, Hammond GD: Prognosis and treatment after relapse of acute lymphoblastic leukemia and non-Hodgkin's lymphoma: 1985. A report from the Childrens Cancer Study Group. Cancer 58:590-594, 1986
37. Kita K, Nishii K, Ohishi K, et al: Frequent gene expression of granulocyte colony-stimulating factor (G-CSF) receptor in CD7+ surface CD3- acute lymphoblastic leukaemia. Leukemia 7:1184-1190, 1993
38. Nishii K, Kita K, Miwa H, et al: c-kit gene expression in Cd7-positive acute lymphoblastic leukemia: Close correlation with expression of myeloid-associated antigen Cd13. Leukemia 6:662-668, 1992
39. Terstappen LW, Huang S, Safford M, et al: Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 77:1218-1227, 1991
40. Krause DS, Ito T, Fackler MJ, et al: Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84:691-701, 1994
41. Silvestri F, Banavali S, Baccarani M, et al: The CD34 hemopoietic progenitor cell associated antigen: Biology and clinical applications. Haematologica 77:265-273, 1992
42. Uckun F, Steinherz P, Sather H, et al: CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-linege acute lymphoblastic leukemia: A Children's Cancer Group study. Blood 88:4288-4295, 1996
43. Shuster JJ, Falletta JM, Pullen DJ, et al: Prognostic factors in childhood T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 75:166-173, 1990
44. Raimondi SC, Behm FG, Roberson PK, et al: Cytogenetics of childhood T-cell leukemia. Blood 72:1560-1566, 1988
45. Ludwig WD, Harbott J, Bartram CR, et al: Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: Experience of the BFM study 86. Recent Results Cancer Res 131:269-282, 1993
46. Thiel E, Kranz BR, Raghavachar A, et al: Prethymic phenotype and genotype of pre-T (CD7+/Er-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia [see comments]. Blood 73:1247-1258, 1989